Seeking Alpha

Momenta Pharmaceuticals Inc. (MNTA)

()

News & PR
Market Currents

Buzz
Twitter: MNTA

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

Sanofi Pulls the Plug on Two Drugs: Biotech's Latest Mishaps

Dec 24 • The Burrill Report • Comment!
Momenta Pharma's M-Enoxaparin: Timing Uncertain, Approval Likely

Oct 7 • Mike Havrilla • 1 Comment
Biotech News Bytes: Genzyme, ImmunoCellular, Momenta, Novo Nordisk

Sep 23 • Mike Havrilla • Comment!
BioMed News Bytes: Arena, Momenta, Vivus

Sep 20 • Mike Havrilla • Comment!
Novartis: Powering into the Multiple Sclerosis Market

Sep 8 • Richard Sater • 3 Comments
Big Movers in Healthcare - JAZZ, HEB, MNTA, MBLX and OCLS

Jun 28 • M. E. Garza • 7 Comments
30 Possible Pandemic Profit Plays: Bullish Biotech and Drug Stocks to Watch

Jun 28 • Marco Hickey • 1 Comment
16 'Bathwater Babies' and 20 'Dogs with Fleas' for the Week

May 26 • J Clinton Hill • 1 Comment
Three Oversold Healthcare Catalyst Stocks

Mar 12 • Mike Havrilla • Comment!
Momenta Pharma Pursuing a Three-Part Strategy

Mar 6 • Mike Havrilla • Comment!
Biotech Going Generic Like Big Pharma?

Mar 2 • Mike Havrilla • 2 Comments
Trading FDA Decisions: Cypress Bioscience Soars, A Trio of Buys

Jan 15 • Mike Havrilla • 4 Comments
20 Emerging Healthcare Stocks to Watch in '09

Jan 11 • Mike Havrilla • 4 Comments
Nine for '09 Picks Start Strong

Jan 9 • Mike Havrilla • 3 Comments
Momenta Pharma's Opportunities Abound

Jan 4 • Mike Havrilla • 1 Comment
Small, Defensive 2009 Stock Picks Are Soaring

Dec 18, 2008 • Mike Havrilla • Comment!
Nine for '09: Staying Defensive in the New Year

Dec 11, 2008 • Mike Havrilla • Comment!
Investment Ideas That Stand Out from ETF Innovators New Indexes

Dec 8, 2008 • Mike Havrilla • Comment!
Stocks Offering 'Healthy' Returns

Nov 25, 2008 • Mike Havrilla • Comment!
Teva Beats On Profits

Nov 6, 2008 • Mike Havrilla • Comment!
Four Biotechs at Attractive Entry Points

Oct 26, 2008 • Mike Havrilla • Comment!
Generic Drug Industry Outperforms Drug and Healthcare ETFs

Oct 17, 2008 • Mike Havrilla • Comment!
Overview and Analysis of the Global Generic Drug Industry

Oct 13, 2008 • Mike Havrilla • Comment!
Momenta Pharma Investors In Waiting Game on Enoxaparin

Oct 6, 2008 • Mike Havrilla • Comment!
Pharmaceuticals: Near Term Movers Based On FDA Decision Dates

Oct 6, 2008 • Mike Havrilla • Comment!
Momenta Pharma: A Waiting Game

Sep 26, 2008 • Mike Havrilla • Comment!
FDA Calendar: Cardiome, Momenta, Discovery Labs, Introgen

Aug 7, 2008 • Mike Havrilla • 2 Comments
Best and Worst Performing Stocks Seven Months Into 2008

Aug 4, 2008 • Bespoke Investment Group • 4 Comments
Another Month of '08 in the Books

May 1, 2008 • Bespoke Investment Group • 1 Comment
Wednesday's Options Report: C, V, BCO, VLO, CBI, MNTA, CLX

Apr 30, 2008 • Andrew Wilkinson • 1 Comment
Momenta Pharma: Expect Upside Following Game-Changing Upgrade

Apr 28, 2008 • Notable Calls • Comment!
Q1's Best and Worst Performing Stocks

Apr 1, 2008 • Bespoke Investment Group • 1 Comment
The Next Great Biotech Short Squeeze

Apr 23, 2007 • Andrew Vaino • Comment!
Is Momenta's Stock Plunge Justified?

Feb 12, 2007 • Anthony Payne • Comment!
Biotech Day In Review: Sanofi Loses Lovenox Patent

Feb 11, 2007 • Centient Biotech Investor • Comment!

Momenta Pharmaceuticals Inc. (MNTA)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers